Genomic Health

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Genomic Health ( GHDX) is a molecular diagnostics company focused on the global development and commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions. This stock is trading up 3.4% at $36.63 in recent trading.

Today's Volume: 213,000

Average Volume: 157,455

Volume % Change: 118%

>>5 Rocket Stocks Ready for Blastoff

From a technical perspective, GHDX is moving notably higher here with above-average volume. This move is quickly pushing GHDX within range of triggering a major breakout trade. That trade will hit once GHDX takes out some past overhead resistance levels at $36.81 to $37.44 with high volume. At last check, GHDX has hit an intraday high of $36.68 and volume is just staring to push above its three-month average action of 157,455 shares.

Traders should now look for long-biased trades in GHDX as long as it's trending above its 50-day at $34.22, and then once it sustains a move or close above those breakout levels with volume that's near or above 157,455 shares. If that breakout triggers soon, then GHDX will have a great chance of entering new 52-week-high territory and trading north of $40.

If you liked this article you might like

Eating McDonald's Stock Might Make You Sick

Investors in Restaurant Stocks Still Need Strong Stomachs

iPhone X, Bitcoin and Nordstrom - 5 Things You Must Know Before the Market Opens

Futures Hold Steady as Hurricane Irma Pummels Florida

Hurricane Irma Batters Florida and Fed Gets Inflation Numbers: Week Ahead